Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 4, 2019
[Immunotherapy in urology: Concept and results]
G Pignot, N Houede
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
March 15, 2011
[Bone prevention in prostate cancer]
T Bessede, N Houede, T Lebret
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 27, 2012
[Intradiverticular bladder tumours: review of the Cancer Committee of the French Association of Urology]
Y Neuzillet, E Comperat, M Rouprêt, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 5, 2013
[Surgical treatment of metastatic urothelial carcinoma of the bladder: Review of the Cancer Committee of the French Association of Urology]
Y Neuzillet, S Larré, E Comperat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
K Fizazi, G Gravis, A Flechon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
January 19, 2016
[Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment]
Y Neuzillet, P Colin, E Comperat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
December 8, 2015
[Molecular, preclinical, and clinical comparative data regarding different strains of bacillus Calmette-Guérin (BCG): Review by the French Urological Association Oncology Committee (CCAFU)]
Y Neuzillet, F Dubosq, E Xylinas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
December 7, 2010
[Recommendations Onco-Urology 2010: Urothelial tumors]
C Pfister, M Roupret, H Wallerand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 14, 2015
[Not Available]
E Compérat, S Larré, Y Neuzillet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)
M Roupret, A Bertaut, G Pignot, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
September 4, 2019
[Immunotherapy in urology: Concept and results]
G Pignot, N Houede
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
March 15, 2011
[Bone prevention in prostate cancer]
T Bessede, N Houede, T Lebret
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
June 27, 2012
[Intradiverticular bladder tumours: review of the Cancer Committee of the French Association of Urology]
Y Neuzillet, E Comperat, M Rouprêt, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 5, 2013
[Surgical treatment of metastatic urothelial carcinoma of the bladder: Review of the Cancer Committee of the French Association of Urology]
Y Neuzillet, S Larré, E Comperat, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
March 6, 2014
Combining gemcitabine, cisplatin, and ifosfamide (GIP) is active in patients with relapsed metastatic germ-cell tumors (GCT): a prospective multicenter GETUG phase II trial
K Fizazi, G Gravis, A Flechon, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
January 19, 2016
[Observational survey of the French Urological Association Oncology Committee (CCAFU) evaluating the practice of immediate postoperative instillation (IPOP) using mitomycin C for non-muscle invasive bladder cancer (NMIBC) treatment]
Y Neuzillet, P Colin, E Comperat, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
December 8, 2015
[Molecular, preclinical, and clinical comparative data regarding different strains of bacillus Calmette-Guérin (BCG): Review by the French Urological Association Oncology Committee (CCAFU)]
Y Neuzillet, F Dubosq, E Xylinas, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
December 7, 2010
[Recommendations Onco-Urology 2010: Urothelial tumors]
C Pfister, M Roupret, H Wallerand, et al.
Progres En Urologie : Journal De L'Association Francaise D'Urologie Et De La Societe Francaise D'Urologie
|
October 14, 2015
[Not Available]
E Compérat, S Larré, Y Neuzillet, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
October 19, 2025
ALBAN (GETUG-AFU 37): a phase III, randomized, open-label international trial of intravenous atezolizumab and intravesical Bacillus Calmette-Guérin (BCG) versus BCG alone in BCG-naive high-risk, non-muscle-invasive bladder cancer (NMIBC)
M Roupret, A Bertaut, G Pignot, et al.
Page
of 1